Straits Times Index
3,217.41 +10.42 (+0.32%) Nikkei
31,857.62 -14.90 (-0.05%) Hang Seng
17,809.66 +436.63 (+2.51%) FTSE 100
7,608.08 +6.23 (+0.08%) Bitcoin USD
26,979.26 -78.17 (-0.29%) CMC Crypto 200
579.66 +0.90 (+0.15%)
Seres Therapeutics, Inc. (MCRB)
After hours:
| Previous close | 2.3900 |
| Open | 2.3900 |
| Bid | 2.3700 x 1300 |
| Ask | 2.6000 x 1000 |
| Day's range | 2.3000 - 2.4600 |
| 52-week range | 2.2800 - 9.4900 |
| Volume | |
| Avg. volume | 2,037,368 |
| Market cap | 305.128M |
| Beta (5Y monthly) | 2.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1800 |
| Earnings date | 31 Oct 2023 - 06 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 9.83 |
- Business Wire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., September 08, 2023--Seres Therapeutics, Inc. (Nasdaq: MCRB) ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on September 6, 2023, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 91,000 shares of its common stock to two new employees, consisting of stock options to purchase an aggregate of 45,500 shares of common stock and restricted stock units ("RSUs"), cove
- Business Wire
Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
CAMBRIDGE, Mass., September 07, 2023--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres management will participate at the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023, at 12:15 p.m. ET.
ZacksSeres Therapeutics (MCRB) Misses Q2 Earnings Estimates
Seres Therapeutics (MCRB) delivered earnings and revenue surprises of -34.55% and 0.78%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
